Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Stock Alert for Affymax Inc. Issued by MicroStockProfit - MarketWatch (press release) |
 |
 |
|
MarketWatch (press release)Its product candidate, Hematide (peginesatide), is designed to treat anemia associated with chronic renal failure. Hematide is a synthetic peptide-based ...Affymax gets $30 million milestone under Hematide accord with Takeda The Pharma LetterPhase 3 trial of investigational drug, Hematide/peginesatide to treat anaemia ... read more |
